The Surveillance, Epidemiology, and End Results (SEER) database is a publicly available, federally funded cancer reporting system that represents a collaboration between the US Centers for Disease Control and Prevention, the National Cancer Institute, and regional and state cancer registries.1 SEER data are national, with information from 18 states that represent all regions of the country. In contrast to other commonly used data sets (eg, the National Cancer Data Base), SEER is population-based, because local registries report information for all cancer cases within a specific region and/or defined racial/ethnic population. Given that SEER data is both a cancer reporting system and a research tool, we aim to present salient aspects of these data, strengths and limitations for analyses, and important statistical considerations.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Doll KM, Rademaker A, Sosa JA. Practical Guide to Surgical Data Sets: Surveillance, Epidemiology, and End Results (SEER) Database. JAMA Surg. 2018;153(6):588–589. doi:10.1001/jamasurg.2018.0501
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: